289 related articles for article (PubMed ID: 3120987)
41. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
[TBL] [Abstract][Full Text] [Related]
42. Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.
Ryan PJ; Gibson T; Fogelman I
J Nucl Med; 1992 Sep; 33(9):1589-93. PubMed ID: 1517830
[TBL] [Abstract][Full Text] [Related]
43. Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.
Adami S; Mian M; Gatti P; Rossini M; Zamberlan N; Bertoldo F; Lo Cascio V
Bone; 1994; 15(4):415-7. PubMed ID: 7917580
[TBL] [Abstract][Full Text] [Related]
44. Treatment of Paget's disease with (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
Frijlink WB; Bijvoet OL; te Velde J; Heynen G
Lancet; 1979 Apr; 1(8120):799-803. PubMed ID: 86042
[TBL] [Abstract][Full Text] [Related]
45. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
Arboleya L; Sánchez J; Iglesias G; Arranz JL
Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
[TBL] [Abstract][Full Text] [Related]
46. Single-day intravenous pamidronate in Paget's disease.
Hooper MJ; Clifton-Bligh P; Marel GM; Lang FV; Tancred J; McDowall D; Forman L
Semin Arthritis Rheum; 1994 Feb; 23(4):276-7. PubMed ID: 8009255
[TBL] [Abstract][Full Text] [Related]
47. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
Patel S; Coupland CA; Stone MD; Hosking DJ
Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
[TBL] [Abstract][Full Text] [Related]
48. Effects of five daily 1 h infusions of alendronate in Paget's disease of bone.
O'Doherty DP; Gertz BJ; Tindale W; Sciberras DG; Survill TT; Kanis JA
J Bone Miner Res; 1992 Jan; 7(1):81-7. PubMed ID: 1549961
[TBL] [Abstract][Full Text] [Related]
49. Pamidronate infusions for the treatment of Paget's disease of bone.
Mazieres B; Ahmed I; Moulinier L; Bon E; Cantagrel A; Laroche M
Rev Rhum Engl Ed; 1996 Jan; 63(1):36-43. PubMed ID: 9064108
[TBL] [Abstract][Full Text] [Related]
50. Duration of response with oral clodronate in Paget's disease of bone.
Khan SA; McCloskey EV; Nakatsuka K; Orgee J; Coombes GM; Kanis JA
Bone; 1996 Feb; 18(2):185-90. PubMed ID: 8833213
[TBL] [Abstract][Full Text] [Related]
51. [Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
González D; Pastrana M; Mautalen C
Medicina (B Aires); 1997; 57 Suppl 1():25-31. PubMed ID: 9567351
[TBL] [Abstract][Full Text] [Related]
52. Intravenously administered pamidronate in the treatment of Paget's disease of bone.
Tucci JR; Bontha S
Endocr Pract; 2001; 7(6):423-9. PubMed ID: 11747277
[TBL] [Abstract][Full Text] [Related]
53. Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates.
Rendina D; Mossetti G; Viceconti R; Sorrentino M; Nunziata V
Calcif Tissue Int; 2004 Sep; 75(3):189-96. PubMed ID: 15148558
[TBL] [Abstract][Full Text] [Related]
54. Paget's disease of bone treated with a five day course of oral tiludronate.
Reginster JY; Lecart MP; Deroisy R; Ethgen D; Zegels B; Franchimont P
Ann Rheum Dis; 1993 Jan; 52(1):54-7. PubMed ID: 8427515
[TBL] [Abstract][Full Text] [Related]
55. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
Chapuy MC; Charhon SA; Meunier PJ
Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
[TBL] [Abstract][Full Text] [Related]
56. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone.
Harinck HI; Bijvoet OL; Blanksma HJ; Dahlinghaus-Nienhuys PJ
Clin Orthop Relat Res; 1987 Apr; (217):79-98. PubMed ID: 2951049
[TBL] [Abstract][Full Text] [Related]
57. Changes in serum HDL and LDL cholesterol in patients with Paget's bone disease treated with pamidronate.
Montagnani A; Gonnelli S; Cepollaro C; Campagna MS; Franci MB; Pacini S; Gennari C
Bone; 2003 Jan; 32(1):15-9. PubMed ID: 12584031
[TBL] [Abstract][Full Text] [Related]
58. Paget's disease of bone treated in five days with AHPrBP (APD) per Os.
Thiébaud D; Jaeger P; Burckhardt P
J Bone Miner Res; 1987 Feb; 2(1):45-52. PubMed ID: 3455156
[TBL] [Abstract][Full Text] [Related]
59. Successful treatment of resistant Paget's disease of bone with pamidronate.
Mallette LE
Arch Intern Med; 1989 Dec; 149(12):2765-7. PubMed ID: 2596945
[TBL] [Abstract][Full Text] [Related]
60. Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget's disease of bone in patients with normal serum alkaline phosphatase levels.
Ang G; Feiglin D; Moses AM
Endocr Pract; 2003; 9(4):280-3. PubMed ID: 14561571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
